Dispatch Bio

Dispatch Bio Develops Cancer Therapies by Harnessing the Immune System. The company focuses on developing treatments that eliminate cancer tumors and prevent their recurrence, offering patients improved cancer care. With its pioneering FLARE immunotherapy platform, Dispatch Bio aims to address two core challenges in solid tumor treatment — the absence of tumor-specific targets and the immunosuppressive microenvironment. This innovation holds the potential to provide a "universal" treatment option for patients with solid tumors, which account for 90% of all cancer cases, bringing disruptive advancements to the field of immunotherapy.